Medicare targets 15 more drugs for price negotiations

HHS Selects 15 New Drugs for Medicare Part D Price Negotiations
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices expected to take effect in 2027.
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.
HHS announces next 15 drugs selected for price negotiations
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price negotiations.
Government picks 15 more prescription drugs for Medicare price negotiation
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has selected 15 additional drugs for pr
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer treatment Calquence, GSK’s chronic obstructive pulmonary disorder (COPD) drug Breo Ellipta, and AbbVie’s antipsychotic medication Vraylar.
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on efforts to reduce prescription drug costs.
Medicare’s 2025 Drug Negotiation List Includes Ozempic and Wegovy
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but expensive weight-loss drugs.
Medicare targets 15 more drugs for price negotiations -- including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
Biden administration adds 15 drugs to Medicare price negotiation list
Medicare enrollees, however, still won’t be able to access the drugs for obesity under a federal law that prohibits the program from paying for weight loss treatments. Right now
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from cancer and type 2 diabetes to asthma.
Fierce Healthcare18h
Former HHS official and Warp Speed leader Paul Mango dies
Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...
STAT4d
Former Trump White House, HHS aide Abe Sutton likely to lead Medicare, Medicaid innovation center
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
JD Supra1d
EnforceMintz —Could the Supreme Court’s Decision in Jarkesy Mean the End to HHS Civil Monetary Penalty Authorities as We Know Them?
Last June, the Supreme Court issued its decision in Securities and Exchange Commission v. Jarkesy, which holds that the ...
HHS Secretary Becerra urges Trump administration to 'continue to grow' the ACA
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
ENDPOINTS NEWS2d
HHS blasts Boehringer's drug price case, re­veals new de­tails on Jar­diance talks
HHS told the Second Circuit that Boehringer Ingelheim’s voluntary participation in Medicare negotiations “undermines” its ...
Becker's Hospital Review3d
Maine health system sues HHS over withheld Medicare payments
Lewiston, Maine-based St. Mary's Health System is suing HHS for allegedly unlawfully withholding Medicare payments from the cash-strapped system, Maine Public Radio reported Jan. 14.
Hosted on MSN4d
After Mandating Vaccines And Censoring Conservatives, Biden’s HHS Sec Wonders Why Nobody Trusts His Agency
Xavier Becerra, President Joe Biden’s outgoing Health and Human Services (HHS) secretary, is lamenting Americans’ abysmal ...
360dx4d
HHS Report Finds Medicare Lab Spending Dropped 5 Percent in 2023 on Lower COVID-19 Volumes
The report also indicates that while PAMA has cut spending on routine tests, overall lab spending has risen as genetic testing continues to grow.